Metacrine is based out of San Diego. Metacrine, Inc. operates as a biotech company. The Company focuses on developing therapeutics for liver, gastrointestinal, and metabolic diseases. Metacrine serves patients worldwide. The firm last filed a Form D notice of exempt offering of securities on 2018-06-20. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
Metacrine, Inc.4225 EXECUTIVE SQUARE
SAN DIEGO CA 92037
Business Phone: 858-369-7800
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
2834-PHARMACEUTICAL PREPARATIONS